PharmaCyte Biotech (PMCB) logo

PharmaCyte Biotech (PMCB) stock

Market cap $3.8MShares as of Sep 11

$0.35
-1.44%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score PMCB. It is too small, priced too low, and too thinly traded for a fair Quality Score.

Healthcare · Biotech

Holding PMCB? An optional alert each time PMCB files: every 8-K and press release, weekends included.

Get an alert when PMCB files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

PMCB's latest filings

10 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why PMCB isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. PMCB is worth about $3.8M, trades at $0.35, and about 89,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.